Targeted Metabolic Profiling of Tricarboxylic Acid (TCA) Cycle Intermediates

Targeted metabolic detection of tricarboxylic acid (TCA) cycle intermediates enables precise, absolute quantification of citrate, alpha-ketoglutarate, succinate, fumarate, malate, and related metabolites in biological samples using validated LC-MS/MS methodology. This comprehensive analytical service supports research in cancer metabolism, mitochondrial dysfunction, immunometabolism, and metabolic disease with high sensitivity, excellent reproducibility, and rigorous quality control.

Technical Overview

The tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, is the central hub of cellular energy metabolism. Located in the mitochondrial matrix, it oxidizes acetyl-CoA derived from carbohydrates, fats, and proteins to generate NADH and FADH2, which fuel oxidative phosphorylation. Beyond energy production, TCA cycle intermediates serve as critical biosynthetic precursors for amino acids, nucleotides, lipids, and heme, and increasingly act as signaling molecules that regulate gene expression, immunity, and hypoxia responses.

Because the concentrations of TCA cycle intermediates sensitively reflect mitochondrial function, enzymatic activity, and metabolic reprogramming, their accurate measurement has become essential in metabolism research. Targeted metabolite detection offers distinct advantages over untargeted profiling: absolute quantification using isotope-labeled internal standards, optimized chromatographic separation of structurally similar analytes, lower limits of detection, and superior reproducibility across batches.

Analytical challenges specific to TCA cycle intermediates include their high polarity and poor retention on conventional reversed-phase columns, rapid enzymatic turnover after sampling, the instability of oxaloacetate, and the chromatographic resolution required to distinguish isomeric compounds such as citrate and isocitrate. Our platform addresses these challenges through rapid sample quenching, cold organic solvent extraction, specialized ion chromatography or HILIC separation, and tandem mass spectrometry in multiple reaction monitoring (MRM) mode.

Testing Samples

Animal Tissue Samples

Solid tissues including liver, heart, skeletal muscle, brain, kidney, adipose tissue, and tumor xenografts or clinical specimens are acceptable. Tissues should be excised rapidly, rinsed briefly to remove blood contamination, snap-frozen in liquid nitrogen, and stored at -80°C. A minimum of 50–100 mg of tissue is recommended per analysis.

Blood and Body Fluid Samples

Plasma, serum, urine, and cerebrospinal fluid can be analyzed. Blood samples should be collected using anticoagulants compatible with metabolite analysis, processed on ice within 30 minutes, and stored at -80°C. Urine samples require volume normalization to creatinine or osmolality. Typical input volumes are 50–200 µL.

Cell Samples

Cultured mammalian cells, primary cells, sorted immune cell subsets, and organelle fractions are suitable. Cell metabolism must be quenched immediately by aspirating medium and adding pre-chilled extraction solvent, or by rapid filtration quenching. A cell count of 1×10⁶ to 5×10⁶ cells per sample is generally sufficient.

Plant and Microbial Samples

Plant leaves, roots, stems, seeds, and fruits, as well as bacteria, yeast, and filamentous fungi, can be profiled. Plant material should be harvested at defined time points, flash-frozen, and ground under liquid nitrogen. Microbial cultures require rapid filtration or centrifugation at low temperature to halt metabolism prior to extraction.

Sample Handling and Shipping Requirements

• Snap-freeze all samples in liquid nitrogen immediately after collection to prevent ex vivo metabolic conversion.
• Store and ship samples on dry ice to maintain an unbroken cold chain.
• Avoid repeated freeze-thaw cycles, which degrade unstable intermediates such as oxaloacetate.
• Provide sample type, weight or cell number, and experimental grouping to ensure appropriate normalization.

Testing Items

The targeted panel covers all canonical TCA cycle intermediates as well as closely connected metabolites that report on cycle entry, exit, and regulatory branching. Each analyte is quantified against an external calibration curve prepared in matrix-matched blanks, with isotope-labeled internal standards correcting for matrix effects and instrument drift.

• Pyruvic acid (pyruvate)
• Citric acid (citrate)
• cis-Aconitic acid
• Isocitric acid
• Alpha-ketoglutaric acid (2-oxoglutarate)
• Succinyl-CoA
• Succinic acid (succinate)
• Fumaric acid (fumarate)
• Malic acid (malate)
• Oxaloacetic acid (oxaloacetate)
• Acetyl-CoA
• Related pathway metabolites: L-lactic acid, L-glutamic acid, L-aspartic acid, and 2-hydroxyglutaric acid (optional)

Deliverables include absolute concentrations (ng/mL or ng/mg tissue or pmol/10⁶ cells), calibration curve parameters, quality control data, and statistical visualization.

Testing Methods

Sample Preparation and Quenching

Biological samples are homogenized or lysed in pre-chilled extraction solvent, typically methanol, acetonitrile, and water mixtures containing isotope-labeled internal standards. This single-step procedure simultaneously quenches enzymatic activity and extracts polar metabolites. Extracts are clarified by centrifugation at 4°C, dried under nitrogen or vacuum, and reconstituted in a solvent compatible with the chromatographic system.

Chromatographic Separation and MS/MS Detection

Given the high polarity and acidity of TCA cycle intermediates, separation is performed using ion chromatography (IC), hydrophilic interaction liquid chromatography (HILIC), or ion-pair reversed-phase LC depending on the analyte panel and matrix. The LC system is coupled to a triple quadrupole mass spectrometer operated in negative electrospray ionization mode with MRM transitions optimized for each target. This configuration provides high selectivity for co-eluting isomers and detection limits in the low nanomolar range.

Method Validation and Quality Control

The method is validated following bioanalytical guidance covering linearity (R² greater than 0.99), accuracy, precision (intra-day and inter-day CV below 15%), recovery, matrix effects, and stability. Each analytical batch includes blank controls, calibration standards at seven concentration levels, and pooled quality control samples injected at regular intervals. Isomeric pairs such as citrate and isocitrate are chromatographically resolved and independently quantified.

Data Processing and Bioinformatics

Raw MRM signals are integrated, normalized to internal standards, and converted to absolute concentrations using batch-specific calibration curves. Bioinformatics support includes group comparison statistics, principal component analysis, partial least squares discriminant analysis, correlation network analysis, and mapping of quantitative results onto the TCA cycle pathway for intuitive biological interpretation.

Applications

Targeted quantification of TCA cycle intermediates is widely applied across biomedical and life science research:

• Cancer metabolism research: characterization of the Warburg effect, mitochondrial respiration defects, and neomorphic IDH mutations that accumulate the oncometabolite 2-hydroxyglutarate.
• Immunometabolism: measurement of succinate as a pro-inflammatory signal that stabilizes HIF-1α, and of itaconate and other immunomodulatory shunt products in macrophage activation.
• Mitochondrial disease and toxicology: evaluation of respiratory chain defects, drug-induced mitochondrial impairment, and energy metabolism dysfunction.
• Metabolic disease research: mechanisms of diabetes, obesity, non-alcoholic fatty liver disease, and insulin resistance.
• Ischemia-reperfusion injury and cardiovascular studies: succinate accumulation during ischemia and ROS burst upon reperfusion.
• Neurodegenerative disease: altered TCA cycle flux and energy failure in Alzheimer's, Parkinson's, and Huntington's disease models.
• Plant physiology and stress biology: TCA cycle remodeling under drought, salinity, and pathogen stress.
• Industrial microbiology: metabolic engineering of microbial strains and fermentation process optimization.
• Stable isotope tracer studies: 13C-glucose, 13C-glutamine, or 13C-palmitate tracing to quantify TCA cycle flux, entry points, and pool turnover.

FAQ

Why is oxaloacetate sometimes reported at low or variable levels?

Oxaloacetate is chemically unstable and decarboxylates rapidly, and it exists at low intracellular steady-state concentrations because it is continuously consumed by citrate synthase and transamination reactions. Rapid quenching, cold-chain handling, and validated extraction protocols minimize artifacts, though biological variability of this metabolite should be interpreted with appropriate controls.

Can citrate and isocitrate be distinguished from each other?

Yes. Although these stereoisomers share identical masses, our chromatographic method resolves them into separate peaks, allowing independent and accurate quantification of each analyte.

What is the typical project turnaround time?

Standard targeted TCA cycle panels are typically completed within 2–4 weeks after sample receipt, depending on sample numbers and the complexity of the project. Stable isotope tracer experiments may require additional time for data modeling.

How should samples be stored and shipped?

All samples must be flash-frozen in liquid nitrogen, stored at -80°C, and shipped on sufficient dry ice with temperature monitoring to preserve metabolite integrity during transit.

How does targeted detection differ from untargeted metabolomics?

Untargeted metabolomics surveys thousands of features with relative quantification and is suited to discovery workflows. Targeted detection focuses on a pre-defined analyte panel, delivering absolute concentrations, higher sensitivity, better quantitative accuracy, and more reliable inter-batch comparability, which is ideal for hypothesis-driven studies and validation.

Is 13C metabolic flux analysis of the TCA cycle available?

Yes. The platform supports isotope-resolved quantification of 13C-labeled intermediates following tracer administration, enabling calculation of relative flux through oxidative and reductive TCA cycle routes, anaplerotic inputs, and pyruvate cycling.